Subclinical deterioration of left ventricular function in patients with juvenile-onset systemic lupus erythematosus

被引:13
|
作者
Chung, H-T [1 ]
Huang, Y-L [2 ,3 ]
Yeh, K-W [4 ]
Huang, J-L [3 ,4 ]
机构
[1] Chang Gung Mem Hosp Linkou, Dept Pediat, Div Cardiol, Taoyuan, Taiwan
[2] Chang Gung Mem Hosp Keelung, Dept Pediat, Keelung, Taiwan
[3] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan
[4] Chang Gung Mem Hosp Linkou, Dept Pediat, Div Asthma Allergy & Rheumatol, Taoyuan, Taiwan
关键词
Ventricular function; systemic lupus erythematosus; pediatric rheumatology; cardiovascular disease; DIASTOLIC FUNCTION; DISEASE-ACTIVITY; CARDIAC ABNORMALITIES; INVOLVEMENT; DYSFUNCTION; CHILDREN; ECHOCARDIOGRAPHY; RECOMMENDATIONS; CARDIOMYOPATHY; ADOLESCENTS;
D O I
10.1177/0961203314554249
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Patients with systemic lupus erythematosus (SLE) have a higher risk of myocardial involvement, which can result in ventricular dysfunction. Little is known about the chronic influence of SLE on heart function in children and adolescents. This is the first study to demonstrate long-term changes in left ventricular function in patients with juvenile-onset SLE. Methods: This was a longitudinal study of 92 patients with juvenile-onset SLE. Two-dimensional echocardiography was performed by a single pediatric cardiologist at baseline, with follow-up at six-month intervals. Clinical and laboratory parameters, disease activity, treatment, nailfold capillaroscopy, and the traditional risk factors for atherosclerosis were evaluated. The baseline comparison of ventricular function was performed against 50 age-matched controls, and the follow-up results were analyzed using generalized estimating equations. Results: The patients' mean age at baseline was 15.9 +/- 4.3 years, the mean disease duration was 3.6 +/- 3.2 years, and the mean follow-up duration was 4.5 +/- 1.6 years. At baseline, the mean left ventricular ejection fraction (LVEF) was 74.7 +/- 5.6% and the mean E/A ratio of left ventricular diastolic filling was 1.7 +/- 0.3 (E: the peak velocity at rapid left ventricular filling; A: the peak velocity during left atrial contraction). The LVEF of the SLE patients was similar to the healthy controls and it did not change during the follow-up period. In contrast, the E/A ratio was lower in the SLE patients than in the healthy controls (1.7 +/- 0.3 versus 1.88 +/- 0.37; p=0.002), and it decreased significantly with time (B +/- SE, -0.013 +/- 0.006, p=0.023). In multiple analyses, abnormal microvasculature in nailfold capillaroscopy had a negative effect on LVEF progression (p=0.039). Disease duration of SLE and proteinuria were risk factors associated with the descent of E/A ratio (p=0.014 and p=0.015, respectively). Conclusion: In patients with juvenile-onset SLE who were free of cardiac symptoms, there was evidence of declining ventricular diastolic function with time. Abnormal nailfold microvasculature, proteinuria and longer disease duration were the main risk factors for worsening of ventricular function.
引用
收藏
页码:263 / 272
页数:10
相关论文
共 50 条
  • [41] Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature
    Chiewchengchol, Direkrit
    Murphy, Ruth
    Edwards, Steven W.
    Beresford, Michael W.
    PEDIATRIC RHEUMATOLOGY, 2015, 13
  • [42] Ventricle disfunction in juvenile-onset systemic lupus erythematosus with renal involvement
    Sampaio, L.
    Moura, C.
    Costa, P.
    Pinto, H.
    Afonso, C.
    Brito, I.
    PEDIATRIC NEPHROLOGY, 2011, 26 (09) : 1712 - 1713
  • [43] RENAL BIOMARKERS IN A COHORT OF CHILDREN WITH JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS
    Watson, Louise
    Midgley, A.
    Hanna, L.
    Jones, C.
    Holt, R.
    Pilkington, C.
    Tullus, K.
    Beresford, M. W.
    RHEUMATOLOGY, 2011, 50 : i9 - i9
  • [44] Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus (jS']jSLE)
    Natoli, Valentina
    Charras, Amandine
    Hahn, Gabriele
    Hedrich, Christian M.
    MOLECULAR AND CELLULAR PEDIATRICS, 2023, 10 (01)
  • [45] SERUM ADIPOKINES AND VASCULAR PHENOTYPE IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS
    Quinlan, C.
    Petrasca, A.
    Kari, J.
    Pilkington, C.
    Deanfield, J.
    Shroff, R.
    Marks, S.
    Tullus, K.
    NEPHROLOGY, 2014, 19 : 64 - 65
  • [46] Low disease activity state in juvenile-onset systemic lupus erythematosus
    Ozturk, Kubra
    Caglayan, Sengul
    Tanatar, Ayse
    Baglan, Esra
    Otar, Gulcin Yener
    Kayaalp, Gulsah Kavrul
    Karadag, Serife Gul
    Demir, Ferhat
    Sonmez, Hafize Emine
    Ozdel, Semanur
    Cakan, Mustafa
    Ayaz, Nuray Aktay
    Sozeri, Betul
    LUPUS, 2021, 30 (13) : 2144 - 2150
  • [47] Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature
    Direkrit Chiewchengchol
    Ruth Murphy
    Steven W Edwards
    Michael W Beresford
    Pediatric Rheumatology, 13
  • [49] Oral Ulcers in Juvenile-Onset Systemic Lupus Erythematosus: A Review of the Literature
    Pongsawat Rodsaward
    Titipong Prueksrisakul
    Tawatchai Deekajorndech
    Steven W. Edwards
    Michael W. Beresford
    Direkrit Chiewchengchol
    American Journal of Clinical Dermatology, 2017, 18 : 755 - 762
  • [50] Oral Ulcers in Juvenile-Onset Systemic Lupus Erythematosus: A Review of the Literature
    Rodsaward, Pongsawat
    Prueksrisakul, Titipong
    Deekajorndech, Tawatchai
    Edwards, Steven W.
    Beresford, Michael W.
    Chiewchengchol, Direkrit
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2017, 18 (06) : 755 - 762